These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 37210951)

  • 21. Synthesis of 1,2-benzisoxazole tethered 1,2,3-triazoles that exhibit anticancer activity in acute myeloid leukemia cell lines by inhibiting histone deacetylases, and inducing p21 and tubulin acetylation.
    Ashwini N; Garg M; Mohan CD; Fuchs JE; Rangappa S; Anusha S; Swaroop TR; Rakesh KS; Kanojia D; Madan V; Bender A; Koeffler HP; Basappa ; Rangappa KS
    Bioorg Med Chem; 2015 Sep; 23(18):6157-65. PubMed ID: 26299825
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Synthesis and evaluation of new Hsp90 inhibitors based on a 1,4,5-trisubstituted 1,2,3-triazole scaffold.
    Taddei M; Ferrini S; Giannotti L; Corsi M; Manetti F; Giannini G; Vesci L; Milazzo FM; Alloatti D; Guglielmi MB; Castorina M; Cervoni ML; Barbarino M; Foderà R; Carollo V; Pisano C; Armaroli S; Cabri W
    J Med Chem; 2014 Mar; 57(6):2258-74. PubMed ID: 24588105
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Design, synthesis and biological evaluation of novel 1,2,3-triazole linked coumarinopyrazole conjugates as potent anticholinesterase, anti-5-lipoxygenase, anti-tyrosinase and anti-cancer agents.
    Chekir S; Debbabi M; Regazzetti A; Dargère D; Laprévote O; Ben Jannet H; Gharbi R
    Bioorg Chem; 2018 Oct; 80():189-194. PubMed ID: 29940340
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Quinazoline Based HSP90 Inhibitors: Synthesis, Modeling Study and ADME Calculations Towards Breast Cancer Targeting.
    El-Shafey HW; Gomaa RM; El-Messery SM; Goda FE
    Bioorg Med Chem Lett; 2020 Aug; 30(15):127281. PubMed ID: 32527460
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Synthesis of Oridonin Derivatives via Mizoroki-Heck Reaction and Click Chemistry for Cytotoxic Activity.
    Hou W; Fan Q; Su L; Xu H
    Anticancer Agents Med Chem; 2019; 19(7):935-947. PubMed ID: 30657049
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Design, synthesis and biological evaluation of 17-arylmethylamine-17-demethoxygeldanamycin derivatives as potent Hsp90 inhibitors.
    Li Z; Jia L; Wang J; Wu X; Hao H; Xu H; Wu Y; Shi G; Lu C; Shen Y
    Eur J Med Chem; 2014 Oct; 85():359-70. PubMed ID: 25105924
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Unravelling the anticancer potency of 1,2,4-triazole-N-arylamide hybrids through inhibition of STAT3: synthesis and in silico mechanistic studies.
    Turky A; Bayoumi AH; Sherbiny FF; El-Adl K; Abulkhair HS
    Mol Divers; 2021 Feb; 25(1):403-420. PubMed ID: 32830299
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Thermodynamic Analysis of the Geldanamycin-Hsp90 Interaction in a Whole Cell Lysate Using a Mass Spectrometry-Based Proteomics Approach.
    Xu Y; Wallace MA; Fitzgerald MC
    J Am Soc Mass Spectrom; 2016 Oct; 27(10):1670-6. PubMed ID: 27530778
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Molecular characterization of macbecin as an Hsp90 inhibitor.
    Martin CJ; Gaisser S; Challis IR; Carletti I; Wilkinson B; Gregory M; Prodromou C; Roe SM; Pearl LH; Boyd SM; Zhang MQ
    J Med Chem; 2008 May; 51(9):2853-7. PubMed ID: 18357975
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Synthesis of bioactive and fluorescent pyridine-triazole-coumarin peptidomimetics through sequential click-multicomponent reactions.
    Soumya TV; Muhammed Ajmal C; Bahulayan D
    Bioorg Med Chem Lett; 2017 Feb; 27(3):450-455. PubMed ID: 28062094
    [TBL] [Abstract][Full Text] [Related]  

  • 31. New bis- and tetrakis-1,2,3-triazole derivatives: Synthesis, DNA cleavage, molecular docking, antimicrobial, antioxidant activity and acid dissociation constants.
    Nural Y; Ozdemir S; Yalcin MS; Demir B; Atabey H; Seferoglu Z; Ece A
    Bioorg Med Chem Lett; 2022 Jan; 55():128453. PubMed ID: 34801684
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Regioselective approach to colchiceine tropolone ring functionalization at C(9) and C(10) yielding new anticancer hybrid derivatives containing heterocyclic structural motifs.
    Pyta K; Skrzypczak N; Ruszkowski P; Bartl F; Przybylski P
    J Enzyme Inhib Med Chem; 2022 Dec; 37(1):597-605. PubMed ID: 35067138
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Click chemistry to probe Hsp90: Synthesis and evaluation of a series of triazole-containing novobiocin analogues.
    Peterson LB; Blagg BS
    Bioorg Med Chem Lett; 2010 Jul; 20(13):3957-60. PubMed ID: 20570149
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ganetespib (STA-9090), a nongeldanamycin HSP90 inhibitor, has potent antitumor activity in in vitro and in vivo models of non-small cell lung cancer.
    Shimamura T; Perera SA; Foley KP; Sang J; Rodig SJ; Inoue T; Chen L; Li D; Carretero J; Li YC; Sinha P; Carey CD; Borgman CL; Jimenez JP; Meyerson M; Ying W; Barsoum J; Wong KK; Shapiro GI
    Clin Cancer Res; 2012 Sep; 18(18):4973-85. PubMed ID: 22806877
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Novel Symmetrical 1,4-Disubstituted-bis-1,2,3-Triazoles: Synthesis by Double CuAAC and Cytotoxicity Evaluation.
    Reis WJ; Moreira POL; Alves RB; Oliveira HHM; Silva LM; Varotti FP; Freitas RP
    Curr Top Med Chem; 2018; 18(17):1475-1482. PubMed ID: 30345921
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Synthesis and anti-proliferative activity of allogibberic acid derivatives containing 1,2,3-triazole pharmacophore.
    Wu MJ; Wu DM; Chen JB; Zhao JF; Gong L; Gong YX; Li Y; Yang XD; Zhang H
    Bioorg Med Chem Lett; 2018 Aug; 28(14):2543-2549. PubMed ID: 29884535
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hybrids of 4-hydroxy derivatives of goniothalamin and piplartine bearing a diester or a 1,2,3-triazole linker as antiproliferative agents.
    Grigolo TA; Braga CB; Ornelas C; Russowsky D; Ferreira-Silva GA; Ionta M; Pilli RA
    Bioorg Chem; 2021 Nov; 116():105292. PubMed ID: 34509797
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Design, synthesis, biological evaluation and molecular docking study of 2,4-diarylimidazoles and 2,4-bis(benzyloxy)-5-arylpyrimidines as novel HSP90 N-terminal inhibitors.
    Yang M; Li C; Li Y; Cheng C; Shi M; Yin L; Xue H; Liu Y
    J Enzyme Inhib Med Chem; 2022 Dec; 37(1):2551-2565. PubMed ID: 36120957
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Green Approach Toward Triazole Forming Reactions for Developing Anticancer Drugs.
    Rastogi SK; Ciliberto VC; Trevino MZ; Campbell BA; Brittain WJ
    Curr Org Synth; 2024; 21(4):380-420. PubMed ID: 37157212
    [TBL] [Abstract][Full Text] [Related]  

  • 40. "Click-and-click"--hybridised 1,2,3-triazoles supported Cu(I) coordination polymers for azide-alkyne cycloaddition.
    Jiang L; Wang Z; Bai SQ; Hor TS
    Dalton Trans; 2013 Jul; 42(26):9437-43. PubMed ID: 23695801
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.